AAAAAA
Results:
1-11
|
Results: 11
Authors:
Birebent, B
Somasundaram, R
Purev, E
Li, WP
Mitchell, E
Hoey, D
Bloom, E
Mastrangelo, M
Maguire, H
Harris, DT
Staib, L
Braumuller, H
Leeser, C
Kuttner, N
Beger, HG
Herlyn, D
Citation: B. Birebent et al., Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients, CR R ONC H, 39(1-2), 2001, pp. 107-113
Authors:
BenAmmar-Ceccoli, S
Humblot, S
Crouzier, R
Acres, B
Kieny, MP
Herlyn, D
Pasquali, JL
Martin, T
Citation: S. Benammar-ceccoli et al., Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth, CANC GENE T, 8(10), 2001, pp. 815-826
Authors:
Li, J
Pereira, S
Van Belle, P
Tsui, P
Elder, D
Speicher, D
Deen, K
Linnenbach, A
Somasundaram, R
Swoboda, R
Herlyn, D
Citation: J. Li et al., Isolation of the melanoma-associated antigen p23 using antibody phage display, J IMMUNOL, 166(1), 2001, pp. 432-438
Authors:
Trebak, M
Begg, GE
Chong, JM
Kanazireva, EV
Herlyn, D
Speicher, DW
Citation: M. Trebak et al., Oligomeric state of the colon carcinoma-associated glycoprotein GA733-2 (Ep-CAM/EGP40) and its role in GA733-mediated homotypic cell-cell adhesion, J BIOL CHEM, 276(3), 2001, pp. 2299-2309
Authors:
Staib, L
Birebent, B
Somasundaram, R
Purev, E
Braumuller, H
Leeser, C
Kuttner, N
Li, WP
Zhu, DW
Diao, J
Wunner, W
Speicher, D
Beger, HG
Song, H
Herlyn, D
Citation: L. Staib et al., Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients, INT J CANC, 92(1), 2001, pp. 79-87
Authors:
Daly, T
Royal, RE
Kershaw, MH
Treisman, J
Wang, G
Li, WP
Herlyn, D
Eshhar, Z
Hwu, P
Citation: T. Daly et al., Recognition of human colon cancer by T cells transduced with a chimeric receptor gene, CANC GENE T, 7(2), 2000, pp. 284-291
Authors:
Maruyama, H
Zaloudik, J
Li, WP
Sperlagh, M
Koido, T
Somasundaram, R
Scheck, S
Prewett, M
Herlyn, D
Citation: H. Maruyama et al., Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine, CANCER IMMU, 49(3), 2000, pp. 123-132
Authors:
Somasundaram, R
Robbins, P
Moonka, D
Loh, E
Marincola, F
Patel, A
Guerry, D
Herlyn, D
Citation: R. Somasundaram et al., CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells, INT J CANC, 85(2), 2000, pp. 253-259
Authors:
Braumuller, H
Leeser, C
Herlyn, D
Beger, HG
Staib, L
Citation: H. Braumuller et al., Immunomonitoring during active-specific immunotherapy in pancreatic and colorectal cancer, LANG ARCH S, 1999, pp. 279-283
Authors:
Herlyn, D
Birebent, B
Citation: D. Herlyn et B. Birebent, Advances in cancer vaccine development, ANN MED, 31(1), 1999, pp. 66-78
Authors:
Trebak, M
Chong, JM
Herlyn, D
Speicher, DW
Citation: M. Trebak et al., Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology, J IMMUNOL M, 230(1-2), 1999, pp. 59-70
Risultati:
1-11
|